Meaghan Kall Profile picture
Jan 16, 2023 18 tweets 10 min read Read on X
NEW: @UKHSA Variant Technical Briefing 49

🔘 XBB.1.5 and CH.1.1 designated variants

🔘 BQ.1 severity and VE estimates

assets.publishing.service.gov.uk/government/upl…
Start with overall variant picture for England to 1 Jan:

This is Omicron soup. 🍜 Each colour a different Omicron lineage.

BQ.1.1 in light purple 🟣 is the most common at 51% of cases

CH.1.1 in yellow 🟡 is 20% and growing

XBB.1.5 in dark red 🔴 is 4.5% and growing
🛑 sampling bias warning❗️

English sequenced cases are *highly* skewed to older ages, due to prioritising samples for sequencing from hospital patients and care homes.

The median age of English 🏴󠁧󠁢󠁥󠁮󠁧󠁿 sequenced COVID-19 cases is

76 years old 👴🏻 👵🏻
So where possible, it is more informative to restrict analysis to community cases from ONS survey.

Smaller numbers but a closer reflection of the population.

When we do, we do see a similar pattern. Reassuring — no variant appears to be driving infection in elderly.
Now to the new variant designations CH.1.1 and XBB.1.5

There’s a lot of interest in XBB.1.1 already, so I’ll focus on CH.1.1 first.

CH.1.1 has been growing steadily in UK since early Nov.

Origin country unknown, but UK reports more CH.1.1 than any other country.
About half of CH.1:1 sequences are from 🇬🇧 but it is reported in >60 countries globally incl New Zealand, Denmark, USA and Austria, Australia, Japan

Its a BA.2.75 sub-lineage with a bunch of antigenic mutations which make it immune evasive

@LongDesertTrain details more ⤵️
Why is CH.1.1 interesting?

Because I’m England 🏴󠁧󠁢󠁥󠁮󠁧󠁿 it’s currently in head-to-head competition with XBB.1.5 in UK.

Although it has had a head start, it’s still spreading quickly and seemingly unhindered by XBB.1.5
How do the immune evasion profiles compare?

This data from @yunlong_cao shows CH.1.1 and XBB.1.5 have similar neutralisation titres versus vaxxed + BA.5 breakthrough infection
But, XBB.1.5 remains a concern.

While numbers XBB.1.5 are small in this analysis (n~130)

XBB.1.5 is showing a higher growth rate than CH.1.1 (relative to BA.5) in England
🛑 I’ve warned about over interpretation of early growth rates before ⤵️

UKHSA data is no exception. As I said above, we’d prefer to restrict growth rates to ONS survey data alone. But couldn’t because XBB.1.5 numbers were too small yet.

So interpret with caution…
That said, evidence is accumulating to suggest that XBB.1.5 does have the edge in infectiousness

Due to the double nucleotide change at 486 increasing spike affinity to ACE2

h/t @yunlong_cao @SystemsVirology
So my sense is that XBB.1.5 will eventually come to dominate.

Meanwhile, it is plausible that CH.1.1 and XBB.1.5 will grow in tandem and cooperate to increase COVID incidence in England 🏴󠁧󠁢󠁥󠁮󠁧󠁿 over the next few weeks. The size of wave is unclear, but unlikely to be BA.1/BA.2 levels.
In terms of severity of XBB.1.5, we have some early reassuring data from @PeacockFlu lab at @imperialcollege

XBB (parent lineage) acts like previous Omicron lineages with the altered entry pathway and preference for nasal 👃 cell tissue over lung 🫁
We will keep a very close eye on the mutations XBB picks up, especially on spike.

As @PeacockFlu notes, #F486P may act as evolutionary credit, covering the cost of new mutations, even if detrimental, but over time such rapid evolution can result in some nasty new variants…
FINALLY:

🔺New BQ.1 vaccine & severity analysis

• Risk of Hospitalisation with BQ.1 (after A&E attendance): aOR 1.06 (0.97-1.17) vs BA.5

• Vaccine effectiveness vs hospitalisation:
BQ.1 —>50% (35-62%)
BA.5 —>64% (53-72%)

BQ.1 lower but overlapping CIs.
Well done as ever to @meera_chand & crew

@freja_kirsebom for the VE analysis

@epb41l2 and @giulia_seghezzo for the severity analysis

And many others…!

Pre-prints coming soon on some of the early data presented here. 👍🏻
Correction - this is growth relative to BQ.1.1 (not BA.5)
Eek correction 2: CH.1.1 is dark red chunk at top right, XBB.1.5 light yellow sliver at bottom right

I’m about to pay for that damn edit button you know 😑

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Meaghan Kall

Meaghan Kall Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kallmemeg

Aug 7
Guess I can’t put this off any longer. Yesterday was officially my last day, and my bio must be updated…

After 15 amazing years, I am leaving UKHSA to start a 4-year @FPH specialty training programme in public health.

Pls indulge a short thread🧵 Image
When I got a job at the (then) Health Protection Agency in 2009 I told @dopapus and @vanessa_apea it was my dream job.

And it really was.

Wrangling real-world data. Influencing policy. Improving health. This is all within reach working at a public health agency. And I loved it.
Working for 10 years in the national HIV surveillance team, developing Positive Voices, the largest HIV patient survey in the world, is truly the highlight of my career.

To be able to give patients a voice in @UKHSA routine public health data has been an enormous honour.
Image
Image
Read 11 tweets
Dec 6, 2023
NEW: @UKHSA COVID-19 Variant Prevalence and Growth Rates

✅ JN.1 has been designated variant V-23DEC-01 due to increasing sequence prevalence in the UK and internationally.

gov.uk/government/pub…
Image
JN.1 is a BA.2.86 sub-lineage (BA.2.86.1.1), which contains the L455S mutation in Spike, known to aid immune evasion.

There are currently 223 cases in England. Image
As mid-November, JN.1 represented 7.9% of cases in England 🏴󠁧󠁢󠁥󠁮󠁧󠁿

At that time, JN.1 had a weekly estimated* growth rate advantage of 84% (64%-104%) against current XBB background

*model adjusted for geography and clustering
Image
Image
Read 5 tweets
Aug 18, 2023
NEW: @UKHSA variant risk assessment just published

⚠️ BA.2.86 designated a variant V-23AUG-01

gov.uk/government/pub…
Image
Been a while since I have done a Friday night data drop thread!

But important to note this is a risk assessment, rather than a data report, due to limited numbers of sequences (6 cases in 4 countries at time of publication)
The assessment was performed today by UKHSA public health teams in collaboration with counterparts in EW&NI, academics & clinicians.

Key points:

• The geographical distribution of cases without travel history “suggests there is established international transmission” Image
Read 11 tweets
Aug 2, 2023
NEW: @UKHSA COVID-19 Variant Prevalence and Growth Rates published

EG.5.1 is declared a variant (V-23JUL-01)

https://t.co/gqVsvmqD63gov.uk/government/pub…
Image
EG.5.1 is a derivative of the Omicron XBB lineage, the currently dominant strain in the UK.

A variant is declared if it is growing in prevalence and is considered significant enough to justify further characterisation. Image
Globally, EG.5.1 accounts for:

• 20% of sequences from Asia
• 10% of sequences from Europe
• 7% of sequences from North America.

Latest data shows EG.5.1 is 12% of sequences in the UK

{this % is likely be higher today due to sequencing/reporting lag} Image
Read 6 tweets
Apr 26, 2023
ICYMI: @UKHSA published a new COVID-19 variant technical briefing

🧬 XBB.1.16 update and designated variant V-23APR-01

assets.publishing.service.gov.uk/government/upl… Image
Current variant landscape🇬🇧

🔺XBB lineages dominate, now over 70% of sequenced cases

🔺XBB.1.5 led the takeover of BQ.1 and CH.1.1 earlier this year

🔺 XBB.1.16 (in pink below) is a small but increasing fraction

(Context will be relevant later on...) Image
XBB.1.16

First emerged in February 2023, XBB.1.16 has shown marked growth in India 🇮🇳 coupled with increasing cases and deaths there.

It also appears to be growing in other countries like the USA 🇺🇸, Singapore 🇸🇬, Brunei 🇧🇳 and Australia 🇦🇺 Image
Read 14 tweets
Jan 27, 2023
ICYMI: 🏴󠁧󠁢󠁥󠁮󠁧󠁿 GOV.UK Dashboard has changed how it presents COVID-19 deaths

@ONS death certificates are now the leading measure, replacing deaths within 28 days

This is because 28-day deaths is no longer a good proxy for COVID-19 deaths. A short thread🧵
This stems from a joint analysis between @UKHSA and @ONS, led by the brilliant @giulia_seghezzo

We have been monitoring how closely the 28-day deaths tracks COVID-19 death certificates.

khub.net/documents/1359…
Remember: deaths within 28-days was only ever a proxy for COVID deaths. It does not consider cause of death, because that information is too delayed.

@UKHSA 28-day deaths

✅ Pros: rapid measure, shows changing trends
❌ Cons: not specific to cause of death
Read 13 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(